Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (161-170 of 508) with videos related to

Pageof 51
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and HypertensionEmmanuelle Vidal-Petiot, Nicola Greenlaw, Ian Ford, et al.
BMJ Open|May 24, 2015
SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in ScotlandJennifer Logue, Sally Stewart, Jane Munro, et al.
Lancet (London, England)|September 4, 2016
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort studyEmmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, et al.
Clinical Cardiology|December 4, 2020
Use of risk scores to identify lower and higher risk subsets among COMPASS-eligible patients with chronic coronary syndromes. Insights from the CLARIFY registryArthur Darmon, Gregory Ducrocq, Adam Jasilek, et al.
BMJ Open|August 9, 2015
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertensionMorris J Brown, Bryan Williams, Thomas M MacDonald, et al.
The Journal of Heart Valve Disease|August 12, 2006
Our inability to predict thromboembolic events after prosthetic valve surgeryMalcolm B Will, Gillian M Bernacca, Elizabeth F Bell, et al.
Journal of Managed Care & Specialty Pharmacy|September 1, 2016
Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United StatesJeffrey S Borer, Anuraag R Kansal, Emily D Dorman, et al.
European Journal of Preventive Cardiology|October 25, 2021
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery diseaseNadia Bouabdallaoui, Nathan Messas, Nicola Greenlaw, et al.
Controlled Clinical Trials|December 31, 2002
Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trialJerry Avorn, Josh Benner, Ian Ford, et al.
BMJ Open|August 9, 2015
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertensionBryan Williams, Thomas M MacDonald, Mark Caulfield, et al.
Pageof 51

Showing results (161-170 of 508) with videos related to

Sort By:
Pageof 51
Hypertension (Dallas, Tex. : 1979)|November 1, 2017
Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and HypertensionEmmanuelle Vidal-Petiot, Nicola Greenlaw, Ian Ford, et al.
BMJ Open|May 24, 2015
SurgiCal Obesity Treatment Study (SCOTS): protocol for a national prospective cohort study of patients undergoing bariatric surgery in ScotlandJennifer Logue, Sally Stewart, Jane Munro, et al.
Lancet (London, England)|September 4, 2016
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort studyEmmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, et al.
Clinical Cardiology|December 4, 2020
Use of risk scores to identify lower and higher risk subsets among COMPASS-eligible patients with chronic coronary syndromes. Insights from the CLARIFY registryArthur Darmon, Gregory Ducrocq, Adam Jasilek, et al.
BMJ Open|August 9, 2015
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertensionMorris J Brown, Bryan Williams, Thomas M MacDonald, et al.
The Journal of Heart Valve Disease|August 12, 2006
Our inability to predict thromboembolic events after prosthetic valve surgeryMalcolm B Will, Gillian M Bernacca, Elizabeth F Bell, et al.
Journal of Managed Care & Specialty Pharmacy|September 1, 2016
Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United StatesJeffrey S Borer, Anuraag R Kansal, Emily D Dorman, et al.
European Journal of Preventive Cardiology|October 25, 2021
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery diseaseNadia Bouabdallaoui, Nathan Messas, Nicola Greenlaw, et al.
Controlled Clinical Trials|December 31, 2002
Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trialJerry Avorn, Josh Benner, Ian Ford, et al.
BMJ Open|August 9, 2015
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertensionBryan Williams, Thomas M MacDonald, Mark Caulfield, et al.
Pageof 51